BRIEF-Mingzhu Logistics Agrees To Acquire Oxylus Global Company Targeting Continued Aggressive Diversification And Growth Acceleration Strategy-February 2024-www.financetom.com

BRIEF-Mingzhu Logistics Agrees To Acquire Oxylus Global Company Targeting Continued Aggressive Diversification And Growth Acceleration Strategy

News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities

BRIEF-Mingzhu Logistics Agrees To Acquire Oxylus Global Company Targeting Continued Aggressive Diversification And Growth Acceleration Strategy

May 31, 2024 2:20 PM

MingZhu Logistics Holdings Ltd ( YGMZ ):

* MINGZHU LOGISTICS AGREES TO ACQUIRE OXYLUS GLOBAL; COMPANY

TARGETING CONTINUED AGGRESSIVE DIVERSIFICATION AND GROWTH

ACCELERATION STRATEGY

Source text for Eikon:

Further company coverage:

Previous page： --Global Net Lease Keeps Quarterly Dividend at $0.275 a Share; Payable Oct. 16 to Shareholders of Record as of Oct. 11 Next page： Main Street Capital Unit Increases Credit Facility, Lowers Interest Rate

Comments

Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.

Show More Comments

Related Articles >

--Global Net Lease Keeps Quarterly Dividend at $0.275 a Share; Payable Oct. 16 to Shareholders of Record as of Oct. 11

Oct 2, 2024

07:57 AM EDT, 10/01/2024 (MT Newswires) -- Price: 8.47, Change: +0.05, Percent Change: +0.59 ...

Main Street Capital Unit Increases Credit Facility, Lowers Interest Rate

Oct 2, 2024

07:57 AM EDT, 10/01/2024 (MT Newswires) -- Main Street Capital ( MAIN ) said Tuesday that its subsidiary MSCC Funding I has amended its revolving credit facility to increase its total commitments to $600 million from $430 million. The company said it maintained an option that allows for an increase of up to $800 million in total commitments from new...

Ionis Pharmaceuticals Says FDA Granted Fast Track Designation to Zilganersen to Treat Alexander Disease

Oct 2, 2024

07:55 AM EDT, 10/01/2024 (MT Newswires) -- Ionis Pharmaceuticals ( IONS ) said Tuesday that the US Food and Drug Administration has granted fast-track designation to zilganersen for the treatment of children and adults with a neurological disorder called Alexander disease. The company said it expects topline data from its study of zilganersen in the second half of 2025, for...

Cymbria Reports Increase in Value of Investment in EdgePoint

Oct 2, 2024

07:58 AM EDT, 10/01/2024 (MT Newswires) -- Cymbria (CYB.TO) said overnight Monday that the value of its investment in EdgePoint Wealth Management increased to about $295.7 million from nearly $255 million. The investment company expects this to result in an increase to Cymbria's A share aNAV of about 2.4% or $1.80 per share. After the revaluation, Cymbria said EdgePoint will...